UBE2V2 Antikörper (AA 2-145) (HRP)

Produktnummer ABIN1994539

Produktdetails anti-UBE2V2 Antikörper (HRP)

Target: UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))

Bindungsspezifität: AA 2-145

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UBE2V2 Antikörper ist konjugiert mit HRP

Applikation: ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 protein (2-145AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin^TM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freeze.
Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu UBE2V2

Target: UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))

Andere Bezeichnung: UBE2V2 (UBE2V2 Produkte)

Synonyme: DDVIT1 antikoerper, DDVit-1 antikoerper, EDAF-1 antikoerper, EDPF-1 antikoerper, EDPF1 antikoerper, MMS2 antikoerper, UEV-2 antikoerper, UEV2 antikoerper, mms2 antikoerper, uev2 antikoerper, edpf1 antikoerper, uev-2 antikoerper, ddvit1 antikoerper, edaf-1 antikoerper, edpf-1 antikoerper, ddvit-1 antikoerper, 1110021H13Rik antikoerper, 4632410D19Rik antikoerper, 5730524P06Rik antikoerper, 6820402M05 antikoerper, AI848315 antikoerper, C81524 antikoerper, wu:fb18b11 antikoerper, wu:fb24d11 antikoerper, zgc:63717 antikoerper, UBE2V2 antikoerper, TMEM189-UBE2V1 antikoerper, ubiquitin conjugating enzyme E2 V2 antikoerper, ubiquitin-conjugating enzyme E2 variant 2 antikoerper, ubiquitin conjugating enzyme E2 V2 S homeolog antikoerper, Ubiquitin-conjugating enzyme E2 variant 2 antikoerper, UBE2V2 antikoerper, Ube2v2 antikoerper, ube2v2 antikoerper, ube2v2.S antikoerper, PTRG_00824 antikoerper, ub2v2 antikoerper, Tsp_08004 antikoerper

Hintergrund:

Background: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through \'Lys-63\'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage.

Aliases: 1 alpha 25 dihydroxyvitamin D3 inducible antibody, DDVit 1 antibody, DDVIT1 antibody, EDAF-1 antibody, EDAF1 antibody, EDPF-1 antibody, EDPF1 antibody, Enterocyte differentiation associated factor EDAF 1 antibody, Enterocyte differentiation promoting factor antibody, Enterocyte differentiation-associated factor 1 antibody, Enterocyte differentiation-promoting factor 1 antibody, Methyl methanesulfonate sensitive 2 antibody, MMS 2 antibody, MMS2 antibody, MMS2 homolog antibody, UB2V2_HUMAN antibody, UBE2V 2 antibody, UBE2V2 antibody, Ubiquitin conjugating enzyme E2 variant 2 antibody, Ubiquitin conjugating enzyme E2v2 antibody, Ubiquitin-conjugating enzyme E2 variant 2 antibody, UEV 2 antibody, UEV2 antibody, Vitamin D3 inducible protein antibody, Vitamin D3-inducible protein antibody

UniProt: Q15819

Pathways: Positive Regulation of Response to DNA Damage Stimulus